These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 11313828

  • 1. MHC class II presentation of endogenously expressed antigens by transfected dendritic cells.
    Diebold SS, Cotten M, Koch N, Zenke M.
    Gene Ther; 2001 Mar; 8(6):487-93. PubMed ID: 11313828
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M, Pfeifer J, Stockinger B, Wick MJ.
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mouse Schwann cells activate MHC class I and II restricted T-cell responses, but require external peptide processing for MHC class II presentation.
    Meyer zu Hörste G, Heidenreich H, Mausberg AK, Lehmann HC, ten Asbroek AL, Saavedra JT, Baas F, Hartung HP, Wiendl H, Kieseier BC.
    Neurobiol Dis; 2010 Feb; 37(2):483-90. PubMed ID: 19914379
    [Abstract] [Full Text] [Related]

  • 10. The class II MHC-restricted presentation of endogenously synthesized ovalbumin displays clonal variation, requires endosomal/lysosomal processing, and is up-regulated by heat shock.
    Michalek MT, Benacerraf B, Rock KL.
    J Immunol; 1992 Feb 15; 148(4):1016-24. PubMed ID: 1737924
    [Abstract] [Full Text] [Related]

  • 11. Impaired ability of MHC class II-/- dendritic cells to provide tumor protection is rescued by CD40 ligation.
    Hermans IF, Ritchie DS, Daish A, Yang J, Kehry MR, Ronchese F.
    J Immunol; 1999 Jul 01; 163(1):77-81. PubMed ID: 10384102
    [Abstract] [Full Text] [Related]

  • 12. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors.
    Lee JM, Mahtabifard A, Yamada R, Crystal RG, Korst RJ.
    Clin Cancer Res; 2002 Nov 01; 8(11):3561-9. PubMed ID: 12429647
    [Abstract] [Full Text] [Related]

  • 13. Deoxyribonucleic acid (DNA) encoding a pan-major histocompatibility complex class II peptide analogue augmented antigen-specific cellular immunity and suppressive effects on tumor growth elicited by DNA vaccine immunotherapy.
    Teramoto K, Kontani K, Ozaki Y, Sawai S, Tezuka N, Nagata T, Fujino S, Itoh Y, Taguchi O, Koide Y, Asai T, Ohkubo I, Ogasawara K.
    Cancer Res; 2003 Nov 15; 63(22):7920-5. PubMed ID: 14633722
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effective induction of anti-tumor immune responses with oligomannose-coated liposome targeting to intraperitoneal phagocytic cells.
    Ikehara Y, Shiuchi N, Kabata-Ikehara S, Nakanishi H, Yokoyama N, Takagi H, Nagata T, Koide Y, Kuzushima K, Takahashi T, Tsujimura K, Kojima N.
    Cancer Lett; 2008 Feb 18; 260(1-2):137-45. PubMed ID: 18077084
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.